Home › Compare › TMBBY vs ABBV
TMBBY yields 9.67% · ABBV yields 3.06%● Live data
📍 TMBBY pulled ahead of the other in Year 1
Combined, TMBBY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TMBBY + ABBV for your $10,000?
TMBThanachart Bank Public Company Limited, together with its subsidiaries, provides various commercial banking products and services to individuals, small and medium sized enterprises (SME), and corporate customers primarily in Thailand. It operates through Commercial Banking and Retail Banking segments. The company offers basic, current, cash concentration, corporate liquidity, term and foreign currency deposit, multi-currency, and savings accounts; working capital, personal, home, auto, credit card, long-term, unsecured, and other loans, as well as special funding programs for SME, letter of guarantee, and supply chain solutions; and debit, credit, and corporate cards. It also provides trade finance, foreign exchange and currency, financial management, hire purchase, finance leasing, bancassurance, and mutual funds, asset management, insurance brokerage, investment banking and advisory, import and export trading, payment, collection, liquidity management, capital market risk management, agency, and other financial services. In addition, the company offers wealth banking, mobile and Internet banking services; mutual funds; and business and properties protection, life and health, personal accident, motor, and travel insurance products. As of December 31, 2021, it operated 636 branches; 3,043 ATMs; and 598 CDMs. The company was formerly known as TMB Bank Public Company Limited and changed its name to TMBThanachart Bank Public Company Limited in May 2021. TMBThanachart Bank Public Company Limited was founded in 1957 and is headquartered in Bangkok, Thailand.
Full TMBBY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.